Patients (n) | 14 |
---|---|
mean value ± SD (min-max) | |
Age, years | 62.1 ± 8.7 (48–76) |
BMI, kg/m2 | 22.6 ± 2.2 (19.1–26.0) |
Tumor diameter, cm | 9.2 ± 3.9 (5.0–21.1) |
Albumin, g/L | 37.7 ± 5.6 (28–51) |
Total Protein, g/L | 69.0 ± 8.9 (43–80) |
Hemoglobin, g/L | 107.9 ± 23.5 (73–150) |
N (%) | |
Sex | |
Male | 9 (64.3%) |
Female | 5 (35.7%) |
ASA score | |
2 | 11 (78.6%) |
3 | 3 (21.4%) |
Clinical symptoms | |
No clinical symptoms | 1 (7.1%) |
Local symptoms | 4 (28.6%) |
Systemic symptoms | 3 (21.4%) |
Both | 6 (42.9%) |
cN stage | |
cN0 | 4 (28.6%) |
cN1 | 10 (71.4%) |
cM stage | |
cM0 | 10 (71.4%) |
cM1 | 4 (28.6%) |
Mayo classification | |
II | 8 (57.1%) |
III | 3((21.4%) |
IV | 3((21.4%) |